Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bankole A Johnson

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Archives of General Psychiatry|September 8, 2004
Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trialBankole A Johnson, Nassima Ait-Daoud, Fatema Z Akhtar, et al.
Alcoholism, Clinical and Experimental Research|February 17, 2005
Safety and efficacy of GABAergic medications for treating alcoholismBankole A Johnson, Robert M Swift, Giovanni Addolorato, et al.
Alcoholism, Clinical and Experimental Research|November 27, 2008
Characterization of a functional polymorphism in the 3' UTR of SLC6A4 and its association with drinking intensityChamindi Seneviratne, Weihua Huang, Nassima Ait-Daoud, et al.
Drug and Alcohol Dependence|October 2, 2021
A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysisDerek Blevins, Chamindi Seneviratne, Xin-Qun Wang, et al.
The American Journal of Psychiatry|July 31, 2013
Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetronBankole A Johnson, Chamindi Seneviratne, Xin-Qun Wang, et al.
Psychopharmacology|March 29, 2002
Ondansetron reduces the craving of biologically predisposed alcoholicsBankole A Johnson, John D Roache, Nassima Ait-Daoud, et al.
Addictive Behaviors|June 1, 2005
A prospective, open-label trial of ondansetron in adolescents with alcohol dependenceMichael A Dawes, Bankole A Johnson, Nassima Ait-Daoud, et al.
Journal of Studies on Alcohol and Drugs|March 22, 2014
Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trialsDaniel E Falk, Raye Z Litten, Raymond F Anton, et al.
Experimental and Clinical Psychopharmacology|February 5, 2014
Acute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol's reinforcing effects in male alcohol preferring (P) ratsCatherine F Moore, Matthew D Lycas, Colin W Bond, et al.
Journal of Clinical Psychopharmacology|June 23, 2004
Effects of isradipine on cocaine-induced subjective moodBankole A Johnson, John D Roache, Nassima Ait-Daoud, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Archives of General Psychiatry|September 8, 2004
Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trialBankole A Johnson, Nassima Ait-Daoud, Fatema Z Akhtar, et al.
Alcoholism, Clinical and Experimental Research|February 17, 2005
Safety and efficacy of GABAergic medications for treating alcoholismBankole A Johnson, Robert M Swift, Giovanni Addolorato, et al.
Alcoholism, Clinical and Experimental Research|November 27, 2008
Characterization of a functional polymorphism in the 3' UTR of SLC6A4 and its association with drinking intensityChamindi Seneviratne, Weihua Huang, Nassima Ait-Daoud, et al.
Drug and Alcohol Dependence|October 2, 2021
A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysisDerek Blevins, Chamindi Seneviratne, Xin-Qun Wang, et al.
The American Journal of Psychiatry|July 31, 2013
Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetronBankole A Johnson, Chamindi Seneviratne, Xin-Qun Wang, et al.
Psychopharmacology|March 29, 2002
Ondansetron reduces the craving of biologically predisposed alcoholicsBankole A Johnson, John D Roache, Nassima Ait-Daoud, et al.
Addictive Behaviors|June 1, 2005
A prospective, open-label trial of ondansetron in adolescents with alcohol dependenceMichael A Dawes, Bankole A Johnson, Nassima Ait-Daoud, et al.
Journal of Studies on Alcohol and Drugs|March 22, 2014
Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trialsDaniel E Falk, Raye Z Litten, Raymond F Anton, et al.
Experimental and Clinical Psychopharmacology|February 5, 2014
Acute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol's reinforcing effects in male alcohol preferring (P) ratsCatherine F Moore, Matthew D Lycas, Colin W Bond, et al.
Journal of Clinical Psychopharmacology|June 23, 2004
Effects of isradipine on cocaine-induced subjective moodBankole A Johnson, John D Roache, Nassima Ait-Daoud, et al.
Pageof 11